Gene Query: PSMB2

Dataset Description Geneva Score
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 37.48
RIG-I and MDA5 fRIP during KSHV lytic reactivation 37.16
Effect of FGF13 depletion on the H460 cell line 27.03
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 25.37
NRDE2 negatively regulates nuclear exosome functions 25.34
An RNA-centric dissection of host complexes controlling flavivirus infection 25.16
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 25.16
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 22.99
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 22.66
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 20.83
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 19.44
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 18.65
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 17.97
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 17.88
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 17.88
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 17.46
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 17.25
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 17.22
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 17.13
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 16.77
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 16.77
The interplay between SOX4 and SMAD3 in the context of breast cancer 16.08
Crizotinib v. DMSO in SW480 cells 15.94
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 15.79
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 15.69
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.64
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.64
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 15.61
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 15.56
Identification of transcription start sites for human A549 cell line using ReCappable-seq 15.18
Global analysis of enhancer targets: Mosaic-seq 14.93
Cleavage Factor Im as a key regulator of 3’ UTR length 14.55
Solid phase chemistry to covalently and reversibly capture thiolated RNA 14.38
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 14.35
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 14.28
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 14.2
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 13.99
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 13.97
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 13.97
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.54
Single-nucleotide-resolution mapping of HBV promoters using CAGE 13.5
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 13.46
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 13.12
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 13.11
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 12.97
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.92
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 12.83
Unique features and clinical importance of acute alloreactive immune responses 12.77
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.67
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.57
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 12.51
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 12.51
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 12.22
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 12.17
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 12.17
Transcriptomic analyssis following EHMT1/2 inhibition 12.01
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.0
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 11.98
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 11.98
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 11.96
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 11.88
FOXD3 is a novel tumor suppressor in lung cancer 11.85
3’ Uridylation Expands miRNA Target Repertoire 11.74
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 11.72
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.67
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.59
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.59
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.58
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.58
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.46
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 11.41
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 11.2
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.18
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 11.15
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 11.14
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 11.14
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 11.13
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 11.09
Endothelial gene expression analysis 11.09
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 11.06
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 11.02
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 11.01
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 10.94
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.83
CROP-Seq in Primary Human T Cells 10.76
Gene Expression Profiling of SPOP Knocked Down Cell 10.71
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.6
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.6
The human blood-nerve barrier transcriptome 10.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.47
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 10.45
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 10.45
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 10.42
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 10.42
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.36
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 10.35
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 10.29
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 10.27
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.11
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.08
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 10.04
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 10.02
Integrin signaling regulates YAP/TAZ to control skin homeostasis 9.86
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.7
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.65
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.63
Electronic cigarettes 9.59
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.56
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.56
Gene expression profiling of leukemia cells following asparagine depletion 9.51
Sensing self and nonself circular RNAs 9.46
HNRNPL and its RNA Targets in Prostate Cancer 9.28
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 9.28
BCL11B 9.21
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.14
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 9.14
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.12
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.12
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 9.12
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 9.09
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.06
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.03
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.89
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 8.87
A role for ZNF598 in post-transcriptional gene regulation 8.85
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.84
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 8.8
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.75
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.71
Determination of tRNA aminoacylation levels by high throughput sequencing 8.7
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.62
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.57
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.52
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 8.47
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.44
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.44
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 8.43
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.42
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.35
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.35
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.31
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 8.3
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 8.3
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 8.29
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.28
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 8.25
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 8.24
Transcription control by the ENL YEATS domain in acute leukemia 8.24
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 8.24
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 8.15
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.12
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 8.1
RNA sequencing of primary human platelets and in vitro cell lines 8.08
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 8.06
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 8.05
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 8.05
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 8.04
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 8.03
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 7.98
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.92
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.9
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.9
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 7.89
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.86
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.78
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 7.74
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.69
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 7.61
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 7.56
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 7.56
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.55
Primary Human B-cell Temporal Response to CD40L Stimulation 7.55
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 7.51
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.49
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.49
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.47
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.46
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.42
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.42
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.38
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 7.37
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 7.36
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 7.28
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 7.28
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.25
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 7.23
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 7.22
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 7.22
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.2
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.2
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.18
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.18
Global analyses of the effect of different cellular contexts on microRNA targeting 7.18
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 7.18
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.17
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.15
Exogenous rescue of KLHL9 in SF210 cell line 7.12
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 7.11
Downregulation of LATS kinases alters p53 to promote cell migration 7.07
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.03
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.03
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.01
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 7.0
Transcriptional profiles of normal human mature B cells 6.96
RNA-Seq with and without RNase treatment in PCa cell lines 6.96
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.95
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.94
N6-methyladenine DNA Modification in Glioblastoma 6.94
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 6.94
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.91
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.91
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.89
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 6.88
Transcriptional profiling of microglia; current state of the art and future perspectives 6.85
Genome-wide functional assessment of enhancer activities in the human genome 6.83
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.79
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 6.79
Expression level comparison under dividing and quiescent states in human primary fibroblasts 6.79
Stem and effector CD8 T-cells from human cancers 6.77
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 6.77
Identification of renal resident macrophages across species 6.71
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 6.71
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.69
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 6.62
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.62
mRNA expression profile of Lymphocytes 6.58
Transcriptomic analysis of the HOTAIR-regulated genes 6.58
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 6.57
AR-independent prostate cancer is sustained through FGF signaling 6.56
Widespread regulated alternative splicing of single codons accelerates proteome evolution 6.46
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.43
Transcriptome analysis of kidney organoids 6.42
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.4
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 6.39
Expression data from miR340 overexpressing human A549 cells 6.38
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 6.35
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 6.33
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.3
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 6.3
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.28
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.28
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.25
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.25
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.21
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 6.2
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 6.2
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 6.18
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.13
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 6.12
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.08
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 6.08
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 6.08
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.07
Generation of KRAS signatures using immortalized isogenic lung cells. 6.06
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 6.04
Dynamic 3D chromosomal landscapes in acute leukemia 6.04
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.03
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.03
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.99
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.97
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 5.89
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.89
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 5.85
U1 snRNP telescripting regulates size-function stratified human genome 5.8
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.79
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.79
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.75
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.74
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.69
Identification of HOXB13 target genes responsive to BET inhibitors 5.68
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 5.62
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 5.62
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.62
mRNA expression in human DAOY cells 5.59
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 5.56
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 5.56
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.53
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 5.5
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.47
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.47
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.42
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.4
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.38
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.37
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 5.36
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.36
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.28
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.27
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 5.27
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.25
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.24
TAF1 is critical for AE driven leukemogenesis 5.24
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.24
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 5.23
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 5.23
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.23
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.21
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.21
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.2
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 5.19
HEK293 Heat-shock experiment 5.18
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.12
Transcriptome analysis upon C6orf203 silencing 5.1
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.08
RNA-seq analysis of differentiating human erythroblasts 5.06
Energy Metabolism during Anchorage-Independence 5.05
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 5.02
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 5.02
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 5.02
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.97
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.91
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.86
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 4.74
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 4.74
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.74
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.7
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 4.63
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.4
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.39
Positively selected enhancer elements endow tumor cells with metastatic competence 4.37
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.28
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.28
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.22
RNA-seq of RKO cells with cTAZ KO or putback 4.21
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.2
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.18
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.18
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.15
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.13
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.13
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.1
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.1
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.09
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.06
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 4.06
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 4.06
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.98
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.97
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.8
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.78
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.74
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.72
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 3.7
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 3.68
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 3.65
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 3.65
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.62
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.59
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.57
RNA editing in nascent RNA affects pre-mRNA splicing 3.56
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 3.46
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.43
Metastasis in triple-negative breast cancer 3.43
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.35
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.28
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.28
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.27
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.21
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.12
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.09
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.97
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.95
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.93
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.93
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.89
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.89
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.86
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.8
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.79
Ribosome profiling upon inhibition of eIF4A 2.72
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.72
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.72
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.57
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.51
RNA seq with AML (NB4) cells upon FTO inhibition 2.48
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.42
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.41
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.23
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.21
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.15
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.09
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.07
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.03
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.01
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.9
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.88
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.8
FOXP2's impact on the primate transcriptome 1.79
Determining mRNA half-lives on a transcriptome-wide scale 1.78
Transposon-based construction of strand-specific RNA-seq libraries 1.77
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.76
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.75
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.74
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.67
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.67
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.64
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.62
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.6
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.58
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.52
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.49
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.49
A single-cell transcriptome atlas of the human pancreas 1.47
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.45
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.41
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.41
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.4
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.39
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.36
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 1.32
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.3
Differential gene expression profiles in imatinib-resistant cell lines 1.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.28
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.25
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.24
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.24
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.21
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.21
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.21
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.19
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.14
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.14
RNAseq of cell lines with knocked in ESR1 mutations 1.12
RNA polymerase in pre-B-ALL cell lines 1.09
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.03
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.01
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.0
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.98
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.97
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.96
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.96
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.94
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.94
Regulation of highly expressed hCINAP on translatome 0.93
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.86
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.83
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.8
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.78
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.77
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.77
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.77
Enhancer activation during EGF response 0.74
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.7
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 0.69
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.68
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.65
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.65
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.63
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.63
RNA-seq data 0.61
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.6
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.59
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.51
High-resolution comparative analysis of great ape genomes 0.5
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.5
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.49
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 0.48
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.48
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.47
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.46
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.46
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.42
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.42
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 0.42
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.42
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.42
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.4
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.4
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.38
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.36
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.33
Role of cervicovaginal microbiota in genital inflammation 0.33
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.33
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.33
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.26
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.22
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.22
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.21
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.2
Gene expression profiling of KSHV-infected periodontal ligament cells 0.19
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.18
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.17
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.16
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.13
Transcriptome-wide response to synthetic chromatin protein PcTF 0.12
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.11
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.08
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.07
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.05
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.04
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation